On July 29, 2019, Taconic Biosciences announced the launch of the first commercially-available diet-induced MASH rodent model (formerly NASH). These models will help accelerate clinical development of MASH treatments because they are readily-available off-the-shelf at are varying ages already expressing the symptoms of MASH. These models will save researchers months of planning and accelerate the discovery of novel liver failure treatments:
"Aiming to speed up and facilitate the clinical development of liver failure treatments, Taconic launches the first commercially available diet-induced MASH rodent model... there is an increased demand for preconditioned models, since some of the available models require up to 26 weeks to become ready for study, causing time delays for drug discovery."Read the complete article at: outsourcing-pharma.com